Gene · 7343
Papers1,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New Insight Into Mechanisms of Hepatic Encephalopathy: An Integrative Analysis Approach to Identify Molecular Markers and Therapeutic Targets. | Bioinform Biol Insights | 2023 | 36814683 | PubTator, text mining | PubMed |
| A nucleolar long "non-coding" RNA encodes a novel protein that functions in response to stress. | Proc Natl Acad Sci U S A | 2023 | 36812203 | PubTator, text mining | PubMed |
| Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis. | Antibodies (Basel) | 2023 | 36810518 | PubTator, text mining | PubMed |
| Acute hypoxia attenuates resistance exercise-induced ribosome signaling but does not impact satellite cell pool expansion in human skeletal muscle. | FASEB J | 2023 | 36786723 | PubTator, text mining | PubMed |
| Negatively charged, intrinsically disordered regions can accelerate target search by DNA-binding proteins. | Nucleic Acids Res | 2023 | 36774964 | PubTator, text mining | PubMed |
| Ribosome biogenesis factors-from names to functions. | EMBO J | 2023 | 36762427 | PubTator, text mining | PubMed |
| Targeting of Hmo1 to subcompartments of the budding yeast nucleolus. | Mol Biol Cell | 2023 | 36696177 | PubTator, text mining | PubMed |
| Autoantibodies and Clinical Correlations in Polish Systemic Sclerosis Patients: A Cross-Sectional Study. | J Clin Med | 2023 | 36675584 | PubTator, text mining | PubMed |
| Nucleolar Architecture Is Modulated by a Small Molecule, the Inositol Pyrophosphate 5-InsP7. | Biomolecules | 2023 | 36671538 | PubTator, text mining | PubMed |
| Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update. | Antibodies (Basel) | 2023 | 36648887 | PubTator, text mining | PubMed |
| Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations. | J Transl Autoimmun | 2023 | 36619654 | PubTator, text mining | PubMed |
| Diagnostic accuracy and predictive value of autoantibody profiles in patients with systemic sclerosis: a single-center study. | Clin Rheumatol | 2023 | 36604358 | PubTator, text mining | PubMed |
| Layered immunity and layered leukemogenicity: Developmentally restricted mechanisms of pediatric leukemia initiation. | Immunol Rev | 2023 | 36588481 | PubTator, text mining | PubMed |
| Small molecule-mediated disruption of ribosome biogenesis synergizes with FGFR inhibitors to suppress glioma cell growth. | Neuro Oncol | 2023 | 36583853 | PubTator, text mining | PubMed |
| UBTF-internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia. | Genes Chromosomes Cancer | 2023 | 36448876 | PubTator, text mining | PubMed |
| International Consensus Classification of acute lymphoblastic leukemia/lymphoma. | Virchows Arch | 2023 | 36422706 | PubTator, text mining | PubMed |
| Real-time imaging of RNA polymerase I activity in living human cells. | J Cell Biol | 2023 | 36282216 | PubTator, text mining | PubMed |
| AnimalTFDB 4.0: a comprehensive animal transcription factor database updated with variation and expression annotations. | Nucleic Acids Res | 2023 | 36268869 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Oncogenic lesions and molecular subtypes in adults with B-cell acute lymphoblastic leukemia. | Cancer Sci | 2023 | 36106363 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7343/papers?page=11